Beta Agonist Feed Additives Market Analysis

  • Report ID: 3159
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Beta Agonist Feed Additives Market Segmentation:

Product Segment Analysis

The ractopamine segment is estimated to hold 56% share of the of the global beta agonist feed additives market by 2035, because of the numerous benefits associated with the product. The amino acid ractopamine has been shown to stimulate lean muscle growth. About 80% of all beef, swine, and turkeys grown in the US are fed ractopamine (RAC).  In addition, it is more efficient than zilpaterol and enables livestock to grow rapidly while consuming less feed. As a result, more lean meat is found in cattle which is projected to drive the growth of this segment over the forecast period.

Animal Type Segment Analysis

The cattle segment in the beta agonist feed additives market is anticipated to garner significant revenue share. The segment will develop as a result of consumer demand for cow products, such as milk and meat, which are important sources of protein for diets. Dairy products and milk are in constant demand. Cattle therefore need to be given all the necessary minerals, trace elements, and health supplements for improved growth performance to meet the increasing demand for animal-based goods. Regular animal diets produce more, but to boost the cattle's general health and productivity, certain feed additives need to be added. All these factors are responsible for the segment’s growth.

Our in-depth analysis of the global beta agonist feed additives market includes the following segments:

Product

  • Zilpaterol
  •  Ractopamine

 Animal Type

  • Poultry
  • Cattle
  • Sheep
  • Swine
  • Buffalo

Form

  • Liquid Feed Additive
  • Dry Feed Additive

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of beta agonist feed additives is assessed at USD 98.14 billion.

The global beta agonist feed additives market size surpassed USD 94.98 billion in 2025 and is projected to witness a CAGR of over 3.7%, crossing USD 136.59 billion revenue by 2035.

North America is expected to secure a 40% share of the Beta Agonist Feed Additives Market by 2035 as the region’s firmly regulated yet supportive FDA framework and mature livestock ecosystem bolster the adoption of efficiency-enhancing beta-agonist solutions owing to their approved safe use.

Key players in the market include Quality Liquid Feed Quality Liquid Feeds, Zoetis Services LLC, Intervet Inc. (Merck & Co. Inc.), ForFarmers, De Heus Animal Nutrition, Cargill, Incorporated., BASF SE, Zydus Group, Nutreco, Huvepharma Japan Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos